Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Wray

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Pediatrics in Review|November 3, 2020
Pediatric Hematopoietic Stem Cell TransplantEllen Fraint, Mary Jo Holuba, Lisa Wray
Pediatric Blood & Cancer|April 17, 2014
TPMT and MTHFR genotype is not associated with altered risk of thioguanine-related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: a report from the Children's Oncology GroupLisa Wray, Marijana Vujkovic, Thomas McWilliams, et al.
Clinical Breast Cancer|September 3, 2005
Ethnic disparities in adjuvant chemotherapy for breast cancer are not caused by excess toxicity in black patientsKaren Smith, Lisa Wray, Melissa Klein-Cabral, et al.
Leukemia Research Reports|November 26, 2015
Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952Marijana Vujkovic, Aaron Kershenbaum, Lisa Wray, et al.
Frontiers in Immunology|March 12, 2024
Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropeniaJoseph H Oved, Nora M Gibson, Kimberly Venella, et al.
Cancer Research|November 25, 2003
Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancerAngela DeMichele, Anne-Marie Martin, Rosemarie Mick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohortAngela DeMichele, Richard Aplenc, Jeffrey Botbyl, et al.
Transplantation and Cellular Therapy|July 3, 2025
Outcomes of Unrelated Donor Stem Cell Transplantation with Partial T Cell Depletion for Pediatric Patients with HemoglobinopathiesNora M Gibson, Caitlin W Elgarten, Joseph H Oved, et al.
Blood Advances|December 6, 2021
Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemiaAllison Barz Leahy, Yimei Li, Julie-An Talano, et al.
Transplantation and Cellular Therapy|February 12, 2023
Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice GuidelinesEllen Fraint, Hisham Abdel-Azim, Neel S Bhatt, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pediatrics in Review|November 3, 2020
Pediatric Hematopoietic Stem Cell TransplantEllen Fraint, Mary Jo Holuba, Lisa Wray
Pediatric Blood & Cancer|April 17, 2014
TPMT and MTHFR genotype is not associated with altered risk of thioguanine-related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: a report from the Children's Oncology GroupLisa Wray, Marijana Vujkovic, Thomas McWilliams, et al.
Clinical Breast Cancer|September 3, 2005
Ethnic disparities in adjuvant chemotherapy for breast cancer are not caused by excess toxicity in black patientsKaren Smith, Lisa Wray, Melissa Klein-Cabral, et al.
Leukemia Research Reports|November 26, 2015
Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952Marijana Vujkovic, Aaron Kershenbaum, Lisa Wray, et al.
Frontiers in Immunology|March 12, 2024
Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropeniaJoseph H Oved, Nora M Gibson, Kimberly Venella, et al.
Cancer Research|November 25, 2003
Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancerAngela DeMichele, Anne-Marie Martin, Rosemarie Mick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohortAngela DeMichele, Richard Aplenc, Jeffrey Botbyl, et al.
Transplantation and Cellular Therapy|July 3, 2025
Outcomes of Unrelated Donor Stem Cell Transplantation with Partial T Cell Depletion for Pediatric Patients with HemoglobinopathiesNora M Gibson, Caitlin W Elgarten, Joseph H Oved, et al.
Blood Advances|December 6, 2021
Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemiaAllison Barz Leahy, Yimei Li, Julie-An Talano, et al.
Transplantation and Cellular Therapy|February 12, 2023
Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice GuidelinesEllen Fraint, Hisham Abdel-Azim, Neel S Bhatt, et al.
Pageof 2